TuesdayJun 04, 2024 1:12 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Significantly Expands Fr8Radar, Enhancing Fr8App Platform’s Capabilities

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is an innovative logistics technology solutions company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has announced a significant milestone in the expansion of its Fr8Radar module in the first half of 2024, having successfully integrated with 15 new GPS providers, bringing the total number of GPS integrations to 28. “At Freight Technologies, we are committed to advancing the logistics industry through cutting-edge technology,” said Javier Selgas, chief executive officer of Freight…

Continue Reading

MondayJun 03, 2024 3:24 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Reverse Stock Split

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced a 1-for-50 reverse split of its common stock, effective at 4:01 p.m. ET on June 4, 2024. According to the update, beginning on June 5, 2024, the company’s common stock will continue to trade on the Nasdaq Capital Market on a split adjusted basis under the trading symbol CNSP, but will trade under the following new CUSIP number: 18978H300. The move is primarily intended to increase CNSP’s share trading price and bring…

Continue Reading

FridayMay 31, 2024 3:37 pm

TinyGemsBreaks – GEMXX Corp. (GEMZ) Aims to Establish Footprint in Global Energy Landscape

GEMXX (OTC: GEMZ), an established mine-to-market gem enterprise, recently announced that it is actively broadening its business framework to incorporate private equity funding for oil and gas (“O&G”) exploration ventures. “With a large network of global relationships and several strategic alliances recently established, GEMXX is setting the stage to finance the exploration of extensive oil reserves, specifically targeting giant fields with reserves of 500 million barrels and super-giant fields with over 3 billion barrels located primarily in Latin America,” a recent article reads. “By leveraging its comprehensive network in the O&G sector, which includes major global industry players, GEMXX plans…

Continue Reading

FridayMay 31, 2024 3:15 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints VP over EMEA, Reports First European Orders

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has announced a new position to lead Europe sales efforts. The company has named Alain Van Munster as its new vice president of Europe Middle East and Africa (“EMEA”); Alain has spent more than 25 years in the automotive and fleet industries across Europe, Asia and South America, including serving in positions with Copart and Manheim. The company also reported that its first European orders included 93 vehicles, comprised of 40 all-electric Mullen-GO urban delivery vehicles delivered to GAMA in Serbia and 53 commercial vans and trucks sent to Antidoto SA,…

Continue Reading

ThursdayMay 30, 2024 2:10 pm

TinyGemsBreaks – AZZ Inc. (NYSE: AZZ) Closes on Common Stock Public Offering, Including Underwriters’ Option

AZZ (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and coil-coating solutions, has closed on its underwritten public offering. The offering consists of 4,600,000 shares of common stock along with the full exercise of the underwriters' option, which included the purchase of up to 600,000 additional shares of common stock. The shares were offered at a price per share of $70 resulting in gross proceeds of $322 million for the company, before standard deductions, commissions and fees were paid. AZZ anticipates using the funds from the offering for the redemption of all or a portion of the company's 6.0% Series A Convertible…

Continue Reading

ThursdayMay 30, 2024 1:57 pm

TinyGemsBreaks – Asset Marketing Systems Partners to Provide Straightforward Method for Investors to Obtain Medallion Signature Guarantees

Asset Marketing Systems Insurance Services, LLC (“Asset”) is a premier distributor of insurance products specializing in Fixed Index Annuities, Fixed Annuities, Life, and Asset-Based Insurance. Asset today announced a strategic partnership with eSignature Group LLC, a leading provider of online medallion signature guarantees. eSignature is an online ID verification service that enables investors to receive a medallion without having to find a physical branch location and is available to all verified shareholders within the U.S. According to the announcement, this collaboration presents a significant advancement from a compliance, convenience, and technology perspectives. It allows U.S. investors to receive a medallion…

Continue Reading

ThursdayMay 30, 2024 11:31 am

TinyGemsBreaks – ECGI Holdings Inc. (ECGI) Announces Agreement to Convert $2M Debt to Equity

ECGI Holdings (OTC: ECGI), a diversified holding company, is announcing a debt-to-equity conversion. According to the announcement, the creators of the 3(a)(10) have agreed to convert $2 million of debt into equity. This conversion marks a significant milestone in the company’s ongoing efforts to enhance financial stability and maximize shareholder value and represents a pivotal step in its financial optimization strategy. The announcement noted that the move to convert $2 million of debt into equity enables the company to not only reduce its liabilities but also strengthen its balance sheet. “This conversion will alleviate a significant portion of our financial…

Continue Reading

WednesdayMay 29, 2024 1:44 pm

TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Participate at Upcoming BIO International Convention 2024

Predictive Oncology (NASDAQ: POAI), a leader in artificial-intelligence (“AI”)-driven drug discovery and biologics, will be spotlighted at next month’s BIO International Convention 2024. The conference is scheduled for June 3–6, 2024, in San Diego. According to the announcement, Predictive Oncology CEO Raymond Vennare will be presenting a company overview at the gathering. His presentation, titled “Novel AI Driven Insights to Guide Early Drug Discovery,” is slated to begin at 6:45 EDT on June 3, 2023. “We are very pleased to participate in this year’s Bio International Convention, which is the premier gathering of biopharmaceutical stakeholders from around the world,” said…

Continue Reading

TuesdayMay 28, 2024 3:18 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Developing Zero-Emissions Version of Its PowerUP Mobile EV-Charging Truck

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, is developing a zero-emissions version of its mobile EV-charging solution, PowerUP. The solution will be available on Mullen’s Class 3 all-electric cab chassis truck. According to the announcement, PowerUp provides increased versatility and 100% zero emissions power generation that can deliver on-demand, mobile DC fast-charging. The company noted that the shift to a 100% zero-emission model represents its commitment to sustainable transportation solutions while also meeting overwhelming market demand for zero-emission options in the mobile EV-charging space. First introduced in 2023 as a mobile EV-charging truck, the original model utilized a…

Continue Reading

ThursdayMay 23, 2024 12:06 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Selects CRO in Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is partnering with a contract research organization (“CRO”) to conduct its human pilot study #3. According to the announcement, this is the first-ever DehydraTECH(TM)-processed tirzepatide from Zepbound(R) to be tested in a swallowed oral format. The study is designed to evaluate a dual-action GLP-1 (glucagon-like peptide) plus GIP (glucose-dependent insulintropic peptide) in a randomized, crossover investigation that will compare injected Zepbound tirzepatide by Eli Lilly to a compound formulated, DehydraTECH-processed tirzepatide that is derived from Zepbound but in a capsule form. Test articles for the study will be manufactured…

Continue Reading

Contact us: (512) 354-7000